EquityFlow
›
Companies
› Iktos
Iktos
Biotech
· Paris, FR ·
iktos.ai
AI-driven drug discovery and synthesis planning platform
Funding history
Date
Round
Amount
Mar 2023
Series A
Iktos raised EUR15.5M Series A co-led by M Ventures and Debiopharm Innovation Fund, with Omnes Capital.
$15.5M
Investors
Debiopharm Innovation Fund
M Ventures
Omnes Capital
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →